{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:41:23Z","timestamp":1791409283592,"version":"4.3.3"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>We have established the pig, a large natural host animal for influenza, with many physiological similarities to humans, as a robust model for testing the therapeutic potential of monoclonal antibodies (mAbs). In this study we demonstrated that prophylactic intravenous administration of 15 mg\/kg of porcine mAb pb18, against the K160\u2013163 site of the hemagglutinin, significantly reduced lung pathology and nasal virus shedding and eliminated virus from the lung of pigs following H1N1pdm09 challenge. When given at 1 mg\/kg, pb18 significantly reduced lung pathology and lung and BAL virus loads, but not nasal shedding. Similarly, when pb18 was given in combination with pb27, which recognized the K130 site, at 1 mg\/kg each, lung virus load and pathology were reduced, although without an apparent additive or synergistic effect. No evidence for mAb driven virus evolution was detected. These data indicate that intravenous administration of high doses was required to reduce nasal virus shedding, although this was inconsistent and seldom complete. In contrast, the effect on lung pathology and lung virus load is consistent and is also seen at a one log lower dose, strongly indicating that a lower dose might be sufficient to reduce severity of disease, but for prevention of transmission other measures would be needed.<\/jats:p>","DOI":"10.3389\/fimmu.2021.790918","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:35:18Z","timestamp":1639622118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Low Dose Pig Anti-Influenza Virus Monoclonal Antibodies Reduce Lung Pathology but Do Not Prevent Virus Shedding"],"prefix":"10.3389","volume":"12","author":[{"given":"Basudev","family":"Paudyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"McNee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Veronica","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney S.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain R.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elma","family":"Tchilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.06.087","article-title":"Co-Morbidities Associated With Influenza-Attributed Mortality, 1994-2000, Canada","volume":"26","author":"Schanzer","year":"2008","journal-title":"Vaccine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Immune Plasma for the Treatment of Severe Influenza: An Open-Label, Multicentre, Phase 2 Randomised Study","volume":"5","author":"Beigel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00694-18","article-title":"Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza","volume":"62","author":"Ali","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-17","article-title":"Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model","volume":"61","author":"McBride","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00352-20","article-title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection","volume":"64","author":"Lim","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.051","article-title":"Safety and Efficacy of Monoclonal Antibody VIS410 in Adults With Uncomplicated Influenza A Infection: Results From a Randomized, Double-Blind, Phase-2, Placebo-Controlled Study","volume":"40","author":"Hershberger","year":"2019","journal-title":"EBioMedicine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0453TR","article-title":"Anatomy and Bronchoscopy of the Porcine Lung. A Model for Translational Respiratory Medicine","volume":"51","author":"Judge","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/ilar\/ilv002","article-title":"Swine as a Model for Influenza A Virus Infection and Immunity","volume":"56","author":"Rajao","year":"2015","journal-title":"Ilar J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000429","article-title":"Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms","volume":"205","author":"McNee","year":"2020","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1009330","DOI":"10.1371\/journal.ppat.1009330","article-title":"Protective Porcine Influenza Virus-Specific Monoclonal Antibodies Recognize Similar Haemagglutinin Epitopes as Humans","volume":"17","author":"Holzer","year":"2021","journal-title":"PloS Pathog"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/030098589503200606","article-title":"Comparison of the Pathogenicity of Two US Porcine Reproductive and Respiratory Syndrome Virus Isolates With That of the Lelystad Virus","volume":"32","author":"Halbur","year":"1995","journal-title":"Vet Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13567-014-0085-8","article-title":"Heterogeneous Pathological Outcomes After Experimental Ph1n1 Influenza Infection in Ferrets Correlate With Viral Replication and Host Immune Responses in the Lung","volume":"45","author":"Vida\u00f1a","year":"2014","journal-title":"Vet Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502632","article-title":"Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged With Pandemic H1N1 Virus","volume":"196","author":"Morgan","year":"2016","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of Lung Lesion Development and Pro-Inflammatory Cytokine Response in Pigs With Vaccine-Associated Enhanced Respiratory Disease Induced by Challenge With Pandemic (2009) A\/H1N1 Influenza Virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01051-20","article-title":"Molecular Characterization of Influenza C Viruses From Outbreaks in Hong Kong SAR, China","volume":"94","author":"Daniels","year":"2020","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/vr.164.24.760","article-title":"Influenza A (H1N1) Infection in Pigs","volume":"164","author":"Brookes","year":"2009","journal-title":"Vet Rec"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00052-20","article-title":"Airway Delivery of Anti-Influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies","volume":"94","author":"Vigil","year":"2020","journal-title":"J Virol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001086","article-title":"Simultaneous Aerosol and Intramuscular Immunization With Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs","volume":"206","author":"Martini","year":"2021","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800142","article-title":"Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine","volume":"200","author":"Holzer","year":"2018","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102243","article-title":"Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection","volume":"187","author":"Teijaro","year":"2011","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0313180","article-title":"Lung-Resident Memory CD8 T Cells (TRM) are Indispensable for Optimal Cross-Protection Against Pulmonary Virus Infection","volume":"95","author":"Wu","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402975","article-title":"Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection Against Respiratory Virus Challenge Through Rapid IFN-\u03b3 Production","volume":"195","author":"McMaster","year":"2015","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10245","article-title":"Monoclonal Antibodies for Prevention and Treatment of COVID-19","volume":"324","author":"Marovich","year":"2020","journal-title":"Jama"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"n2083","DOI":"10.1136\/bmj.n2083","article-title":"Covid-19: UK Approves First Monoclonal Antibody Treatment","volume":"374","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1167294","article-title":"Preclinical Pharmacokinetics of MHAA4549A, a Human Monoclonal Antibody to Influenza A Virus, and the Prediction of Its Efficacious Clinical Dose for the Treatment of Patients Hospitalized With Influenza A","volume":"8","author":"Gupta","year":"2016","journal-title":"mAbs"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02457-15","article-title":"The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome","volume":"60","author":"Baranovich","year":"2016","journal-title":"Antimicrobial Agents Chemother"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171491","article-title":"Antibody Recognition of a Highly Conserved Influenza Virus Epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Sci (New York NY)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204839","article-title":"A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Sci (New York NY)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human Antibodies Reveal a Protective Epitope That Is Highly Conserved Among Human and Nonhuman Influenza A Viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza","volume":"211","author":"Ramos","year":"2014","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41541-017-0019-3","article-title":"Antibody Therapies for the Prevention and Treatment of Viral Infections","volume":"2","author":"Salazar","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s42003-020-0952-y","article-title":"Triple Combination Therapy of Favipiravir Plus Two Monoclonal Antibodies Eradicates Influenza Virus From Nude Mice","volume":"3","author":"Kiso","year":"2020","journal-title":"Commun Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00109","article-title":"Drugs for Influenza Treatment: Is There Significant News","volume":"6","author":"Principi","year":"2019","journal-title":"Front Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01182-19","article-title":"Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans","volume":"94","author":"Rijal","year":"2020","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5224","article-title":"Protective Monotherapy Against Lethal Ebola Virus Infection by a Potently Neutralizing Antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.04.003","article-title":"Rapid Generation of a Human Monoclonal Antibody to Combat Middle East Respiratory Syndrome","volume":"9","author":"Corti","year":"2016","journal-title":"J Infect Public Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.celrep.2018.10.031","article-title":"A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-Human Primates","volume":"25","author":"Keeffe","year":"2018","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a Human Antibody Cocktail That Deploys Multiple Functions to Confer Pan-Ebolavirus Protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27298","article-title":"Breadth of Neutralization and Synergy of Clinically Relevant Human Monoclonal Antibodies Against HCV Genotypes 1a, 1b, 2a, 2b, 2c, and 3a","volume":"60","author":"Carlsen","year":"2014","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06745-11","article-title":"HIV-1 Neutralization Coverage Is Improved by Combining Monoclonal Antibodies That Target Independent Epitopes","volume":"86","author":"Doria-Rose","year":"2012","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.03.049","article-title":"Cooperativity Enables Non-Neutralizing Antibodies to Neutralize Ebolavirus","volume":"19","author":"Howell","year":"2017","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7198-7206.1997","article-title":"Potent and Synergistic Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Hyperimmune Anti-HIV Immunoglobulin Combined With Monoclonal Antibodies 2F5 and 2G12","volume":"71","author":"Mascola","year":"1997","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61315-5","article-title":"Antigenic Characterization of Novel H1 Influenza A Viruses in Swine","volume":"10","author":"Tapia","year":"2020","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12323","article-title":"Virological Characterization of Influenza H1N1pdm09 in Vietnam, 2010-2013","volume":"9","author":"Nguyen","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0195525","DOI":"10.1371\/journal.pone.0195525","article-title":"The Use of Plant Lectins to Regulate H1N1 Influenza A Virus Receptor Binding Activity","volume":"13","author":"Lee","year":"2018","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12985-019-1258-x","article-title":"Influenza A Virus Hemagglutinin Mutations Associated With Use of Neuraminidase Inhibitors Correlate With Decreased Inhibition by Anti-Influenza Antibodies","volume":"16","author":"Ilyushina","year":"2019","journal-title":"Virol J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/pathogens8040194","article-title":"Antigenic Site Variation in the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09 Viruses Between 2009-2017 in Ukraine","volume":"8","author":"Zolotarova","year":"2019","journal-title":"Pathogens"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e77892","DOI":"10.1371\/journal.pone.0077892","article-title":"Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody","volume":"8","author":"Yasugi","year":"2013","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.09.004","article-title":"Emergent 2009 Influenza A(H1N1) Viruses Containing HA D222N Mutation Associated With Severe Clinical Outcomes in the Americas","volume":"53","author":"Houng","year":"2012","journal-title":"J Clin Virol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03271-12","article-title":"Identification of Critical Residues in the Hemagglutinin and Neuraminidase of Influenza Virus H1N1pdm for Vaccine Virus Replication in Embryonated Chicken Eggs","volume":"87","author":"Wang","year":"2013","journal-title":"J\u00a0Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01639-10","article-title":"Altered Receptor Specificity and Cell Tropism of D222G Hemagglutinin Mutants Isolated From Fatal Cases of Pandemic A(H1N1) 2009 Influenza Virus","volume":"84","author":"Liu","year":"2010","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e25091","DOI":"10.1371\/journal.pone.0025091","article-title":"Effect of D222G Mutation in the Hemagglutinin Protein on Receptor Binding, Pathogenesis and Transmissibility of the 2009 Pandemic H1N1 Influenza Virus","volume":"6","author":"Belser","year":"2011","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e35962","DOI":"10.7554\/eLife.35962","article-title":"Stochastic Processes Constrain the Within and Between Host Evolution of Influenza Virus","volume":"7","author":"McCrone","year":"2018","journal-title":"Elife"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.790918\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:35:22Z","timestamp":1639622122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.790918\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2021.790918"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.790918","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.08.463636","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"article-number":"790918"}}